IT & Data Management
Enhanced Cell Line Productivity Technology to be Introduced by Catalent Biologics at PEGS Europe
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced that Greg Bleck, Ph.D., Global Head of R&D, Catalent Biologics will present at the upcoming annual...
News
Jicon, single-point for pharma and packaging machinery
Founded in 1984, Jicon is a pharmaceutical processing and packaging equipment manufacturer based in Mumbai. From its Bhiwandi plant in suburban Mumbai, it supplies capital equipment for making tablets, capsules, and ointments to pharma formulation plants.
Karan Hemani, a partner...
News
Turkish Cargo keeps growing steadily
According to the international air cargo information provider WACDs September data, the global air cargo brand Turkish Cargo, which serves 126 countries of the world, grew significantly by achieving a tonnage increase of 8.8 percent in a sector wherein...
Drug Research
A2 Biotherapeutics emerges from Stealth Mode to develop tumour cell therapeutics
A2 Biotherapeutics, a biotechnology company developing innovative cell therapies for cancer patients, announced its official launch. The company, founded in 2018 by veteran biotechnology leaders, has a unique and potentially broad solution for the central problem of cancer research...
Drug Research
CDMOs to benefit from rising BTDs, orphan drugs and fast track status
CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt (5th – 7th November 2019) – has released the fourth part of its eponymous 2019 annual Report. Experts Peter Soelkner, Managing Director, Vetter Pharma International GmbH, Stewart...
News
Anaqua Lands Patent Management Deal with the U.S. Army Medical Research and Development Command
Anaqua, the leading provider of innovation and intellectual property management solutions, announced that the U.S. Army Medical Research and Development Command (USAMRDC) has selected the ANAQUA platform to manage its global IP portfolio.
The USAMRDC is the Army's medical materiel...
Drug Research
Bioeq announces Coherus as marketing and distribution partner for its biosimilar to Lucentis in the U.S.
Zürich, Switzerland. Bioeq IP AG has announced that it signed a license and development agreement with Coherus BioSciences, Inc. , under which Coherus will exclusively market and distribute Bioeq’s biosimilar candidate to Lucentis in the United States (U.S.).
Bioeq will...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read